You are here

Fujifilm's Avigan shown to be effective in Phase Three trial for Covid-19

nz_avigan_230974.jpg
Fujifilm Holdings said on Wednesday its Avigan drug reduced viral loads and symptoms of Covid-19 patients, paving the way for regulatory approval in Japan after months of delays.

[TOKYO] Fujifilm Holdings said on Wednesday its Avigan drug reduced viral loads and symptoms of Covid-19 patients, paving the way for regulatory approval in Japan after months of delays.

The Phase Three clinical study of 156 patients showed that those treated with Avigan improved after 11...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes